Spectrum Pharmaceutecals Inc (SPPI)

[antihama]

Not unexpected. Due to Corona virus pandemic, Pozi CC postponed.

Spectrum Pharmaceuticals Cancelled Participation in Upcoming Medical Conference Due to Coronavirus Pandemic
Business Wire•March 17, 2020
Conference call to discuss the data and strategy for the program originally scheduled for 8 a.m. ET on March 18, 2020 has been postponed
Spectrum Pharmaceuticals (NasdaqGS: SPPI), a biopharmaceutical company focused on novel and targeted oncology therapies, today announced that it had to cancel its planned presentation of Phase 2 data for poziotinib from Cohort 1 during the Keynote Forum at the 11th Annual Congress on Pulmonary & Respiratory Medicine in Amsterdam. The data presentation followed by a conference call to discuss the data and the development strategy for poziotinib had been scheduled for March 18, 2020. Management plans to reschedule the presentation and conference call with investors at an appropriate time during the second quarter of 2020.
Spectrum reached its decision as a result of travel restrictions imposed by academic and government authorities in both the U.S. and the Netherlands. The company is committed to the safety and wellbeing of all of its employees, clinical investigators and other health care professionals associated with its development programs.